Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Acquisition

1 Apr 2009 07:00

RNS Number : 8894P
First Derivatives PLC
01 April 2009
 



1 April 2009

First Derivatives plc

(AIM:FDP.L, IEX:GYQ.I)

Acquisition of Hologram

The Board of First Derivatives plc ("First Derivatives" or the "Company") announces that it has acquired Lepton Solutions Pty Limited (trading as "Hologram"), an Australian based technology company headquartered in Adelaide, for a total cash consideration of up to 2.2 million Australian dollars and 400,000 share options (the "Acquisition").  The Acquisition comprises an initial cash payment of 1.0 million Australian dollars In addition the four principals who own 96.4% of Hologram will receive 400,000 share options in First Derivatives (representing 2.9% of the Company's issued share capital). The share options vesting is subject to Hologram and its four principals achieving certain sales targets during the three years ending 31 March 2012. An additional deferred consideration to the four principals of Hologram, is payable, of up to a maximum of 1.2 million Australian dollars in cash.

Founded in 2004, with offices in Sydney and Adelaide, Hologram principals are leaders in the field of Risk Management and Stock Exchange Trading software. Risk management software developed by them was bought by Sungard and is in use in several hundred financial institutions and corporate treasuries worldwide. Their stock exchange trading system which is also currently in use in many stock exchanges around the world was sold to Computershare and is now owned by NASDAQ. In addition Hologram is the exclusive Australasian partner of Kx Systems in the financial services sector which complements First Derivatives exclusive partnership with Kx Systems in the financial services sector for North America, UK and Ireland.

The Acquisition grows First Derivatives existing presence in Asia Pacific and will help accelerate the Company's expansion by enhancing its global service offering. Hologram will also provide another channel to market for the Company's Delta product range for the Financial Services Sector in the areas of Algorithmic Trading, Market Data, Complex Event Processing (CEP) and Risk Management.

First Derivatives' CEO Brian Conlon said "The skills of Hologram's executive team complement those of First Derivatives extremely well and Hologram's product range will slot seamlessly into our Delta product suite. The Hologram principals have a track record of developing and marketing enterprise software in our domain and this expertise adds to our team of world class technology professionals. We continue to invest significant resources in research and development and the acquisition will help us expand our range of applications and adds corporate treasuries to our target customer base. The transaction is a coming together of two very like minded firms with a mutual emphasis on professionalism and a drive to produce market leading software."

Paul Phillips from Hologram said "We are excited about the opportunities that this transaction provides for Hologram. It gives us additional channels to market for our Treasury and Enterprise Risk Management systems and allows us to accelerate our plans by leveraging First Derivatives global presence and expertise in Kx technology. In addition we are looking forward to growing First Derivatives' sales and consulting presence in the Asia Pacific region and the acquisition will also enable us to expand our European operations in our Treasury Risk Consulting Business. 

Contact:

First Derivatives plc

Brian Conlon

 

Tel: +44 (0)28 3025 2242

Charles Stanley Securities

Nominated Adviser

Russell Cook/Carl Holmes

 

Tel: +44 (0)20 7149 6000

Goodbody Corporate Finance 

IEX Adviser

Diane Hodgson/Linda Hickey

 

Tel: +353 1 667 0420

Stakeholder Communications 

Carl Whyte 

Lisa Nugent

Tel: +44 (0)28 9033 9949

Tel: +44 (0) 20 7903 5148

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUUUUACUPBUAG
Date   Source Headline
12th Oct 20207:00 amRNSNotice of Results
30th Sep 20204:27 pmRNSTotal Voting Rights
16th Sep 20207:00 amRNSDirectorate Change
2nd Sep 20203:54 pmRNSIssue of Equity
2nd Sep 20207:00 amRNSTotal Voting Rights
26th Aug 20208:46 amRNSIssue of Equity
20th Aug 20206:10 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSEuronext Growth Dublin Notice
31st Jul 202012:01 pmRNSIssue of Equity and Total Voting Rights
20th Jul 20207:00 amRNSAppointment of Kx Chief Revenue Officer
14th Jul 20207:00 amRNSDirectorate Change
9th Jul 20207:00 amRNSShare Option Plan Awards
9th Jul 20207:00 amRNSEuronext Growth Dublin Notice
8th Jul 20204:07 pmRNSResult of AGM
8th Jul 20207:00 amRNSAGM Statement
7th Jul 202012:02 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSSenior Executive Appointment
3rd Jul 202010:23 amRNSIssue of Equity
2nd Jul 20207:00 amRNSDirectorate Change
30th Jun 20202:35 pmRNSTotal Voting Rights
9th Jun 20208:00 amRNSEuronext Growth Dublin Notice
8th Jun 20204:30 pmRNSNotice of AGM
3rd Jun 20202:33 pmRNSIssue of Equity
1st Jun 202011:00 amRNSTotal Voting Rights
28th May 20207:00 amRNSEuronext Growth Dublin Notice
22nd May 20205:59 pmRNSIssue of Equity - Correction
21st May 20204:19 pmRNSIssue of Equity
19th May 20207:00 amRNSGlobal partnership agreement
19th May 20207:00 amRNSFull year results for the year ended 29 Feb 2020
9th Apr 20207:00 amRNSTrading Statement
31st Mar 202010:06 amRNSTotal Voting Rights
12th Mar 20207:00 amRNSEuronext Growth Dublin Notice
6th Mar 202010:52 amRNSIssue of Equity
17th Feb 20207:00 amRNSMajor oilfield services contract win
31st Jan 202012:01 pmRNSTotal Voting Rights
30th Jan 20207:00 amRNSEuronext Growth Dublin Notice
24th Jan 20202:01 pmRNSIssue of Equity
15th Jan 20207:00 amRNSCEO appointment and Board changes
31st Dec 20199:58 amRNSTotal Voting Rights
17th Dec 20197:00 amRNSEuronext Growth Dublin Notice
12th Dec 20197:00 amRNSEuronext Growth Dublin Notice
11th Dec 20193:10 pmRNSIssue of Equity
11th Dec 20197:50 amRNSHolding(s) in Company
6th Dec 20193:10 pmRNSIssue of Equity
29th Nov 20194:46 pmRNSTotal Voting Rights
15th Nov 20197:00 amRNSEuronext Growth Dublin Notice
8th Nov 20192:32 pmRNSIssue of Equity
5th Nov 20197:00 amRNSInterim results for the six months ended 31.08.19
1st Nov 201910:15 amRNSHolding(s) in Company
8th Oct 20197:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.